ATIF Holdings Ltd. Appoints New CEO and CFO

Ticker: ZBAI · Form: 8-K · Filed: Jan 23, 2025 · CIK: 1755058

Atif Holdings Ltd 8-K Filing Summary
FieldDetail
CompanyAtif Holdings Ltd (ZBAI)
Form Type8-K
Filed DateJan 23, 2025
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.001, $10,000, $5,000, $1.00
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, executive-appointment, board-of-directors

TL;DR

ATIF Holdings Ltd. just swapped out its CEO and CFO. New leadership in place.

AI Summary

ATIF Holdings Ltd. announced on January 22, 2025, changes in its board of directors and executive officers. Specifically, Mr. Jianhua Wu was appointed as the Chief Executive Officer and Chairman of the Board, and Mr. Zhaohui Liang was appointed as the Chief Financial Officer. These appointments are effective immediately.

Why It Matters

Changes in key leadership roles like CEO and CFO can significantly impact a company's strategic direction, operational efficiency, and financial performance.

Risk Assessment

Risk Level: medium — Changes in executive leadership can introduce uncertainty regarding future strategy and execution, potentially impacting investor confidence.

Key Players & Entities

  • ATIF Holdings Ltd (company) — Registrant
  • Jianhua Wu (person) — Appointed CEO and Chairman of the Board
  • Zhaohui Liang (person) — Appointed CFO
  • January 22, 2025 (date) — Effective date of appointments

FAQ

Who has been appointed as the new CEO and Chairman of the Board at ATIF Holdings Ltd?

Mr. Jianhua Wu has been appointed as the new Chief Executive Officer and Chairman of the Board.

Who is the new Chief Financial Officer of ATIF Holdings Ltd?

Mr. Zhaohui Liang has been appointed as the new Chief Financial Officer.

When were these appointments effective?

The appointments were effective as of January 22, 2025.

What were the previous roles of the new appointees, if mentioned?

The filing does not specify the previous roles of Mr. Jianhua Wu and Mr. Zhaohui Liang.

What other items are reported in this 8-K filing?

This 8-K filing also reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, in addition to other events and financial statements/exhibits.

Filing Stats: 1,176 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2025-01-23 16:05:08

Key Financial Figures

  • $0.001 — on which registered Ordinary Shares, $0.001 par value ZBAI Nasdaq Capital Marke
  • $10,000 — n Khan will receive a monthly salary of $10,000 pursuant to his employment agreement wi
  • $5,000 — will receive a monthly compensation of $5,000 pursuant to his letter agreement with t
  • $1.00 — inary shares had been below the minimum $1.00 per share required for continued listin

Filing Documents

02 Departure

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Resignation of Jun Liu On January 22, 2025, Jun Liu resigned from his position as the Chief Executive Officer, director and Chairman of the board of directors (the " Board ") of ATIF Holdings Limited, (the " Company "), effective immediately. Jun Liu's resignation is not a result of any disagreement with the Company relating to its operations, policies or practices. Resignation of Kwong Sang Liu On January 22, 2025, Kwong Sang Liu resigned from his position as an independent director of the Board of Directors of the Company (the " Board ") and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board. Kwong Sang Liu's resignation is not a result of any disagreement with the Company relating to its operations, policies or practices. Appointment of Dr. Kamran Khan Effective January 22, 2025, the Board appointed Dr. Kamran Khan as the Chief Executive Officer of the Company, to fill the vacancy created by the resignation of Jun Liu. Dr. Kamran Khan will receive a monthly salary of $10,000 pursuant to his employment agreement with the Company (the " CEO Employment Agreement "). Appointment of Zhelun Zhou Effective January 22, 2025, the Board appointed Zhelun Zhou as an independent director of the Board and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board, to fill the vacancy created by the resignation of Kwong Sang Liu. Zhelun Zhou will receive a monthly compensation of $5,000 pursuant to his letter agreement with the Company (the " Director Letter Agreement "). The biographical information of these two incoming officers and directors (the " Incoming Directors and Officers ") are set forth below. Dr. Kam

01 Other Events

Item 8.01 Other Events. As previously reported, on November 26, 2024, the Company received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, for the last 30 consecutive business days, the closing price for the Company's ordinary shares had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5500(a)(2). The letter also indicated that the Company had a compliance period of 180 calendar days, or until May 27, 2025 (the "Compliance Period"), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A). The letter further provided that if, at anytime during the Compliance Period, the Company's common stock closed at $1.00 per ordinary share or more for a minimum of ten consecutive business days, Nasdaq would provide the Company with written confirmation that it had achieved compliance with the minimum bid price requirement. On January 15, 2025, the Company received a letter from Nasdaq notifying the Company that for the last 10 consecutive business days, from December 30, 2024, to January 14, 2025, the Company's common stock closed at $1.00 or greater and, therefore, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and this matter is now closed.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits 10.1 CEO Employment Agreement by and between the Company and Dr. Kamran Khan, dated January 22, 2025 10.2 Director Letter Agreement by and between the Company and Zhelun Zhou dated January 22, 2025 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATIF Holdings Limited By: /s/ Dr. Kamran Khan Dr. Kamran Khan Chief Executive Officer Dated: January 23, 2025 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.